The barcode 300819600133 is associated with "BURROUGHS WELLCOME COMPANY SUDFED NASAL DECON," which refers to a nasal decongestant spray previously manufactured by Burroughs Wellcome Company, now part of GlaxoSmithKline (GSK). Here are the details I found regarding this product:
Product Information:
- Type: Nasal decongestant spray
- Active Ingredient: The product likely contains oxymetazoline, a popular and effective nasal decongestant commonly found in similar products.
Label Information:
- The label for this product would have historically included instructions for use and safety information. Due to its age and potentially being an older formulation, further specifics about the exact labeling information are scarce.
Availability and Pricing:
- There is limited availability information on this specific product since it may no longer be actively marketed. Similar products from GSK, which may include other forms of nasal sprays, generally range in price from $5 to $20 depending on the store and region.
Warnings and Concerns:
- The original product labeling likely included warnings about potential side effects, including:
- Rebound congestion: Prolonged use may lead to increased nasal congestion after discontinuation.
- Nasal dryness: Overuse can lead to discomfort in the nasal passages.
- Eye problems: Users may experience issues like blurred vision or burning sensations.
Health-Related Disclaimer:
- As a consumable product, it likely includes warnings about side effects such as drowsiness, dizziness, and nasal dryness. Additionally, a notice may state: "The contents of the bottle may be affected by changes in humidity and temperature. To maintain the effectiveness of the product, avoid exposure to extreme temperatures."
Given the nature of the product and its health-related implications, users should always refer to current medical advice or consult a healthcare provider regarding its use. The details regarding the product's formulation or availability may have changed since its original release.